Dermatology · Immunobullous Disorders (Pemphigus, Pemphigoid, DH)

A 40-year-old man with refractory pemphigus vulgaris receives rituximab at a dose of 375 mg/m2 weekly for 4 weeks. The earliest expected clinical improvement occurs after approximately how many weeks?

  • A 1 to 2 weeks
  • B 12 to 16 weeks
  • C 4 to 6 weeks
  • D 6 to 12 months
Correct answer: C. 4 to 6 weeks

Explanation

After rituximab therapy for pemphigus, C-cell depletion occurs rapidly, but clinical improvement typically begins around 4 to 6 weeks as existing autoantibodies are cleared. C-cell repopulation often occurs by 6 to 12 months, sometimes with relapse. The 375 mg/m2 weekly x 4 protocol is one standard regimen used in pemphigus, though the lymphoma protocol (same dosing) and rheumatoid arthritis protocol (1000 mg x 2) are both used.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Immunobullous Disorders (Pemphigus, Pemphigoid, DH) MCQs

See all Immunobullous Disorders (Pemphigus, Pemphigoid, DH) MCQs →